Xyz secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Reverted edits by Mmir (talk) to last revision by Anmol Pitliya) Tag: Rollback |
||
(4 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Xyz}} | {{Xyz}} | ||
{{CMG}}; {{AE | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Line 11: | Line 11: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the secondary prevention of [disease name]. | |||
OR | OR | ||
Effective measures for the secondary prevention of [disease name] include: | |||
*[Strategy 1] | |||
*[Strategy 2] | |||
*[Strategy 3] | |||
==References== | ==References== |
Latest revision as of 17:26, 18 January 2019
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Xyz secondary prevention On the Web |
American Roentgen Ray Society Images of Xyz secondary prevention |
Risk calculators and risk factors for Xyz secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]